We are live on ! Find out more
CRC

Curi RMB Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 18.93%
This Fund
S&P 500
This Quarter Est. Return
-14.28%
1 Year Est. Return
+18.93%
3 Year Est. Return
+60.65%
5 Year Est. Return
+73.12%
10 Year Est. Return
+312.51%
AUM
$3.92B
AUM Growth
-$248M
Cap. Flow
+$420M
Cap. Flow %
10.73%
Top 10 Hldgs %
18.85%
Holding
1,057
New
177
Increased
296
Reduced
349
Closed
169

Sector Composition

Rank Sector Weight
1 Financials 20.89%
2 Healthcare 7.38%
3 Technology 7.33%
4 Industrials 7.13%
5 Consumer Discretionary 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
726
Netflix
NFLX
$305B
$322K 0.01%
12,030
+4,040
+51% +$121K
DOOR
727
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$321K 0.01%
7,150
-3,000
-30% -$162K
IJJ icon
728
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.91B
$319K 0.01%
4,614
WIA
729
Western Asset Inflation-Linked Income Fund
WIA
$185M
$317K 0.01%
+29,923
New +$323K
ONCE
730
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$316K 0.01%
8,077
-518
-6% -$22.5K
NOC icon
731
Northrop Grumman
NOC
$77.9B
$315K 0.01%
1,288
+8
+0.6% +$2.21K
VWO icon
732
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$313K 0.01%
8,210
-69
-0.8% -$2.67K
CL icon
733
Colgate-Palmolive
CL
$71.6B
$311K 0.01%
5,225
-4
-0.1% -$250
MLM icon
734
Martin Marietta Materials
MLM
$32.6B
$311K 0.01%
+1,810
New +$321K
AVID
735
DELISTED
Avid Technology Inc
AVID
$311K 0.01%
+65,500
New +$378K
GAB icon
736
Gabelli Equity Trust
GAB
$1.77B
$310K 0.01%
62,162
-150,539
-71% -$863K
INDY icon
737
iShares S&P India Nifty 50 Index Fund
INDY
$567M
$310K 0.01%
8,765
KLAC icon
738
KLA
KLAC
$239B
$307K 0.01%
34,360
AIVI icon
739
WisdomTree International AI Enhanced Value Fund
AIVI
$62.6M
$305K 0.01%
8,060
ASTE icon
740
Astec Industries
ASTE
$1.21B
$305K 0.01%
10,105
-2,175
-18% -$82.4K
FNCL icon
741
Fidelity MSCI Financials Index ETF
FNCL
$2.4B
$304K 0.01%
8,800
-2,400
-21% -$90.7K
EVT icon
742
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
$303K 0.01%
+15,965
New +$354K
BMRN icon
743
BioMarin Pharmaceuticals
BMRN
$11.6B
$302K 0.01%
3,549
-200
-5% -$19K
BX icon
744
Blackstone
BX
$108B
$299K 0.01%
10,015
UL icon
745
Unilever
UL
$137B
$299K 0.01%
5,079
-71
-1% -$4.28K
QCOM icon
746
Qualcomm
QCOM
$159B
$297K 0.01%
5,223
-486
-9% -$29.5K
SCHM icon
747
Schwab US Mid-Cap ETF
SCHM
$14.7B
$296K 0.01%
18,549
-1,428
-7% -$25K
ZTS icon
748
Zoetis
ZTS
$32.3B
$296K 0.01%
3,457
-40
-1% -$3.6K
KN icon
749
Knowles
KN
$3.2B
$294K 0.01%
22,075
-11,275
-34% -$165K
MUS
750
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$294K 0.01%
25,982
-31,500
-55% -$357K

Similar funds

Curi RMB Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Curi RMB Capital held 1,057 positions worth $3.92B, down 6% from $4.17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Curi RMB Capital deployed $420M of net new capital in Q4 2018, opening 177 new positions and adding to 296 existing holdings. Its largest new stake was iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036: 959,889 shares worth $20.4M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Ameris Bancorp, an estimated $28.3M trimmed.

  • Curi RMB Capital's largest Q4 2018 buy was iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036: 959,889 shares worth $20.4M.
  • Curi RMB Capital added most to iShares MSCI Emerging Markets ETF in Q4 2018, an estimated $18.5M increase.
  • Curi RMB Capital's biggest Q4 2018 reduction was Ameris Bancorp, cutting an estimated $28.3M.
  • Curi RMB Capital fully exited Core Laboratories in Q4 2018, selling an estimated $16.8M.
  • Curi RMB Capital's ten largest holdings make up 19% of its $3.92B portfolio in Q4 2018.
  • Curi RMB Capital opened 177 new positions and closed 169 in Q4 2018.
  • Curi RMB Capital's portfolio value fell 6% quarter-over-quarter to $3.92B.

Based on Curi RMB Capital's 13F filing for Q4 2018, filed 13 Feb 2019.